Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology

被引:33
|
作者
Hoyt, Clifford C. [1 ]
机构
[1] Akoya Biosci Inc, Malborough, MA USA
关键词
Predictive biomarkers; multiplex immunofluorescence; multispectral imaging; immuno-oncology; clinical workflow; image analysis; automated staining; spatial biology; LUNG-CANCER; EXPRESSION; ASSAY; IMMUNOHISTOCHEMISTRY; REPRODUCIBILITY; ASSOCIATION; NSCLC;
D O I
10.3389/fmolb.2021.674747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As immuno-oncology (I/O) emerges as an effective approach in the fight against cancer, multispectral imaging of multiplex immunofluorescence (mIF) is maturing as an analytical platform. The timing is fortuitous. Due to health economic considerations surrounding the use of I/O, there is an urgent need for tests that accurately predict response to the growing list of available therapies. Multispectral mIF provides several advantages over other biomarker modalities by enabling deeper interrogation of the intricate biology within the tumor microenvironment, including detection of cell-to-cell spatial interactions that correlate with clinical outcomes. It also provides a practical path for generating reliable and reproducible results in a clinically suitable, high-throughput workflow. In this article, we (1) describe the principles behind multispectral mIF; (2) provide advice and recommendations on assay development and optimization and highlight characteristics of a well-performing assay; and (3) discuss the requirements for translating this approach into clinical practice.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Precision immuno-oncology (IO) ISH/IF multiplex panel: Spatial detection of cytokines and IO biomarkers
    Patel, Bhavika
    Dennison, Brenna
    Allen, Stephanie
    Stapleton, Jacob
    Archuleta, Roni
    Rath, Mary Lou
    Mehra, Navi
    Talwalkar, Sameer S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage
    Isaacs, James
    Tan, Aaron C.
    Hanks, Brent A.
    Wang, Xiaofei
    Owzar, Kouros
    Herndon, James E., II
    Antonia, Scott J.
    Piantadosi, Steven
    Khasraw, Mustafa
    CLINICAL CANCER RESEARCH, 2022, 28 (01) : 13 - 22
  • [43] Design for immuno-oncology clinical trials enrolling both responders and nonresponders
    Xu, Zhenzhen
    Zhu, Bin
    Park, Yongsoek
    STATISTICS IN MEDICINE, 2020, 39 (27) : 3914 - 3936
  • [44] Precision immuno-oncology (IO) ISH/IF multiplex panel: Spatial detection of cytokines and IO biomarkers
    Dennison, Brenna
    Allen, Stephanie
    Patel, Bhavika
    Stapleton, Jacob
    Archuleta, Roni
    Rath, Mary Lou
    Mehra, Navi
    Talwalkar, Sameer S.
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Companion diagnostic requirements for spatial biology using multiplex immunofluorescence and multispectral imaging
    Locke, Darren
    Hoyt, Clifford C.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [46] VistaPlex immunofluorescence assay panels provide reliable deep spatial phenotyping for diverse immuno-oncology applications
    Christians, Arne
    Jackson, Charles E.
    Boog, Jannik
    Ingalls, Matthew H.
    Northcutt, Adam
    Cashion, Kayla E.
    Rauer, Jonah
    Kwarta, Karen
    Schwarz, J. Spencer
    Braubach, Oliver
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Cytokine affinity tuning using the AlphaSeq platform to generate targeted immuno-oncology therapeutics
    Swanson, Ryan
    Goodnight, Davis
    Adamo, Jeff
    Minch, Kyle
    Engelhart, Emily
    Lopez, Randolph
    Younger, David
    CANCER RESEARCH, 2023, 83 (08)
  • [48] Development of a natural killer (NK) ImmunoGraft platform for the evaluation of the pharmacodynamics of immuno-oncology therapeutics
    Verma, Bhavana
    Ruggeri, Bruce
    Weidanz, Jon
    Wesa, Amy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [49] Developmentof a murine tumor immunophenotyping platform to support drug discovery anddevelopment in immuno-oncology
    Belmontes, Brian
    Matyas, Stephanie
    O'Brien, Sarah
    Tan, Hong
    Ganley, Kenneth
    Merriam, Kimberly
    Rottman, Jim
    Egen, Jackson
    Beltran, Pedro
    Moody, Gordon
    CANCER RESEARCH, 2016, 76
  • [50] Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
    Sivakumar, Ramya
    Chan, Marina
    Shin, Jiye Stella
    Nishida-Aoki, Nao
    Kenerson, Heidi L.
    Elemento, Olivier
    Beltran, Himisha
    Yeung, Raymond
    Gujral, Taranjit S.
    ONCOIMMUNOLOGY, 2019, 8 (12):